What Is Dexamethasone (Kordexa, Dekort), and What Is It Used For?
Reading tools
In this article
What Is Dexamethasone?
Dexamethasoneis a powerful corticosteroid medication. It is a laboratory-developed analogue of cortisol , a hormone naturally produced by the adrenal glands, but is much more potent and longer acting. Its most common brands in Turkey are Dekort (Deva) and Kordexa (Koçak), and ampoule formulations are also available from various manufacturers.
Dexamethasone has a broader role in oncology than many patients realize. It is not merely a supportive medication that reduces side effects: in certain blood cancers, such as multiple myeloma, it is a treatment that directly kills cancer cells.
Article Summary
- Dexamethasone is 25-30 times more potent than hydrocortisone, has biological effects lasting 36-54 hours , and does not cause salt and water retention . These properties explain why it is preferred for cerebral edema.
- It is used for four distinct purposes in oncology: preventing nausea and vomiting, preventing allergic reactions, treating cerebral edema and direct cancer treatment in myeloma, lymphoma, and leukemia.
- For cerebral edema, lower doses are now preferred: 4-8 mg/day, given once or twice daily. The traditional "16 mg every 6 hours" regimen is unnecessary for most patients.
- In patients receiving immunotherapy, high-dose steroids may reduce treatment effectiveness and should be reduced when possible.
- A daily dose of 3 mg or more lasting longer than 14 days suppresses immunity and precludes administration of live vaccines.
- In our previous article, the pre-docetaxel regimen was confusing and the pregnancy-infertility warning was incorrect; both have been corrected in this article.
How Does It Work?
Dexamethasone binds to the glucocorticoid receptor inside cells. This complex enters the cell nucleus and changes the activity of hundreds of genes. The result is three effects that look different depending on the intended use but arise from the same mechanism:
| Effect | Mechanism | Clinical Significance |
|---|---|---|
| Suppression of inflammation | Production of inflammatory cytokines, such as TNF and interleukins, is stopped; vascular permeability decreases | Resolution of cerebral edema, reduction of swelling, and prevention of allergic reactions |
| Suppression of immunity | Lymphocyte numbers and function decrease | Benefit in autoimmune diseases, but an increased risk of infection |
| Direct cell death | Apoptosis, or programmed cell death, is triggered in cells of lymphoid origin | Therapeutic effects in multiple myeloma, lymphoma, and leukemia |
Why Dexamethasone Rather Than Prednisolone?
There are specific reasons for preferring dexamethasone in oncology:
| Medication | Equivalent Dose | Anti-inflammatory Potency | Salt and Water Retention | Biological Half-life |
|---|---|---|---|---|
| Hydrocortisone | 20 mg | 1 | 2 | 8-12 hours |
| Prednisone / Prednisolone | 5 mg | 4 | 1 | 18-36 hours |
| Methylprednisolone | 4 mg | 5 | 0 | 18-36 hours |
| Dexamethasone | 0.75 mg | 25-30 | 0 | 36-54 hours |
- It does not retain salt or water. Using a fluid-retaining medication for cerebral edema makes the problem being treated worse. Dexamethasone has almost no mineralocorticoid activity.
- It penetrates cerebrospinal fluid well. This explains its advantage over prednisone in acute lymphoblastic leukemia and central nervous system lymphoma.
- It is long acting. A small tablet provides a powerful, long-lasting effect.
- The evidence was generated with dexamethasone. Almost all studies of nausea and vomiting prevention and myeloma have used this molecule.
An often-overlooked pharmacological detail: Dexamethasone's blood half-life is only 3-4 hours, but its biological effects last 36-54 hours. This tenfold difference means that clearance from the blood does not mean its effects have ended. Frequent dosing regimens, such as "every 6 hours," are therefore pharmacologically unnecessary; once- or twice-daily administration usually provides the same effect. This matters for both patient comfort and side effects.
Products and Prices in Turkey
| Product | Manufacturer | Price |
|---|---|---|
| Tablets | ||
| Dekort 0.5 mg, 20 tablets | Deva | 98.15 TL |
| Dekort 0.75 mg, 20 tablets | Deva | 119.23 TL |
| Dekort 4 mg, 20 tablets | Deva | 229.98 TL |
| Dekort 8 mg, 20 tablets | Deva | 571.76 TL |
| Kordexa 0.5 mg, 20 tablets | Koçak | 35.61 TL |
| Kordexa 4 mg, 20 tablets | Koçak | 278.94 TL |
| Kordexa 8 mg, 20 tablets | Koçak | 752.08 TL |
| Ampoules — all 8 mg/2 mL | ||
| Dekort 8 mg/2 mL | Deva | 78.38 TL |
| Onadron 8 mg/2 mL | Menarini | 79.92 TL |
| Deksamet 8 mg/2 mL | Osel | 73.81 TL |
| Gadexon 8 mg/2 mL | Haver Trakya | 56.75 TL |
| Dexoject 8 mg/2 mL | Tüm-Ekip | 53.81 TL |
| Deksametazon-PF 8 mg/2 mL | Polifarma | 43.84 TL |
| Infladox 8 mg/2 mL | Farmalas | 42.62 TL |
| Deksinject 8 mg/2 mL | Rompharm | 37.83 TL |
| Other Formulations | ||
| Deksamet 0.25 mg/5 mL syrup | Osel | 243.50 TL |
Prices reflect August-September 2026 updates. All formulations require a standard white prescription and are reimbursed by SGK; in outpatient care, any physician may prescribe them without a medical report.
There are two different Onadron products; do not confuse them. Onadron 8 mg/2 mL ampoules are for systemic use. Onadron Simple 0.1% eye/ear drops are a completely different product and must not be taken orally or intravenously. Ask your pharmacist about the production status of Kordexa 0.5 mg.
Dexamethasone in Cancer: Four Distinct Purposes
1. Prevention of Chemotherapy-induced Nausea and Vomiting
Dexamethasone is a standard component of antiemetic combinations. On its own it is a moderately potent antiemetic, but its effect increases substantially when combined with 5-HT3 blockers such as ondansetron or palonosetron, NK1 blockers such as aprepitant or netupitant, and olanzapine.
| Chemotherapy Category | Day 1 | Days 2-4 |
|---|---|---|
| Highly emetogenic (cisplatin, etc.) | 12 mg orally or intravenously | 8 mg once daily |
| AC regimen (anthracycline + cyclophosphamide) | 12 mg | Not routinely necessary |
| Carboplatin (AUC ≥4) | 12 mg | Not necessary |
| Moderately emetogenic (without an NK1 blocker) | 8 mg | For delayed nausea, 8 mg on days 2-3 (optional) |
Why 12 mg Rather Than 20 mg? This is the discrepancy patients notice most often. In older studies, the day 1 dose was 20 mg. NK1 blockers such as aprepitant inhibit the liver enzyme CYP3A4 , raising dexamethasone blood levels by approximately twofold . In patients receiving an NK1 blocker, the oral dexamethasone dose is therefore reduced by approximately 50%: 12 mg instead of 20 mg. This is not an inadequate dose, but an equivalent dose. The same rule applies to methylprednisolone, with a 25% reduction intravenously and a 50% reduction orally.
The trend toward reducing dexamethasone is growing. The benefit of steroids in preventing nausea is unquestioned, but insomnia, high blood sugar, agitation, and facial swelling are among the side effects patients find most troublesome. The 2023 MASCC/ESMO update states: Steroids do not need to be continued beyond day 1 after an AC regimen; a 4-day regimen is recommended for highly emetogenic treatments other than AC. The medication making this possible is olanzapine. In a study adding olanzapine to standard triple therapy, the proportion of patients with no nausea in the first 24 hours increased from 45% to 74%and, over the full five-day period, from 22% to 37% . In short, less steroid may now be sufficient for nausea control. Do not make this decision on your own — your oncologist determines your regimen.
2. Prevention of Allergic Reactions (Premedication)
Some chemotherapy medications can cause serious allergic reactions because of their carrier solvents. Dexamethasone is given in advance to prevent these reactions. Regimens differ between medications and are not interchangeable.
| Medication | Dexamethasone Regimen | Purpose |
|---|---|---|
| Docetaxel (general) | 16 mg daily (8 mg in the morning + 8 mg in the evening), for 3 days. Start: the day before chemotherapy. | Prevention of allergy + fluid retention (edema) |
| Docetaxel (prostate cancer, with prednisone) | 8 mg, given 12, 3, and 1 hours before the infusion | Same |
| Paclitaxel | 20 mg orally, approximately 12 and 6 hours before the infusion (2 doses in total). Diphenhydramine and an H2 blocker are also given intravenously. | Prevention of hypersensitivity reactions |
| Pemetrexed | 4 mg twice daily for 3 days: the day before treatment, the treatment day, and the following day | Skin rash prevention |
| Nab-paclitaxel (Abraxane) | Routine premedication is not required. Considered only in patients with a previous reaction. | — |
This section was confusing in our previous article; we are correcting it. The two-dose schedule taken "6 and 12 hours before treatment" is notthe pre-docetaxel regimen. The regimen specified in the product information is:
- The day before chemotherapy : start with 8 mg in the morning + 8 mg in the evening
- The day of chemotherapy: 8 mg in the morning + 8 mg in the evening
- The day after chemotherapy: 8 mg in the morning + 8 mg in the evening
Do not skip premedication. Deciding to skip it because you feel well carries a serious risk with docetaxel and paclitaxel. Allergic reactions most commonly occur during the first two cycles and within the first minutes of infusion; premedication largely eliminates this risk. If you forget your tablets, always tell your team before arriving for chemotherapy. Treatment may be postponed or replacement medication given intravenously.
3. Cerebral Edema and Brain Metastases
Brain tumors and metastases cause fluid to accumulate in surrounding brain tissue, known as vasogenic edema. By increasing intracranial pressure, this edema often causes symptoms sooner than the tumor itself: headache, nausea, vomiting, drowsiness, and weakness. Dexamethasone starts reducing this edema within hours , and its effects are felt within 4-6 hours . It comes close to being the medication that improves patients most rapidly in oncology.
Doses Are Falling, and This Is a Positive Development For years, the standard was a "10 mg loading dose followed by 4 mg every 6 hours," totaling 16 mg daily. The evidence supporting this regimen is less robust than commonly assumed. A randomized study in 1994 compared doses in patients with brain metastases: 4 mg/day, 8 mg/day, and 16 mg/day were compared, and improvement in performance status showed no significant difference; by contrast, with increasing dose and duration, side effects increased.
Current guideline recommendations:
Current guideline recommendations:
- Mild symptoms: initial dose 4-8 mg/day
- Moderate-to-severe symptoms / substantial mass effect: 16 mg/day or more
- Asymptomatic patient without mass effect: steroids are not started
This has practical implications. In review data, patients receiving daily doses above 12 mg had peptic ulcers at a rate of 5.6%, high blood sugar at 6.7%, and steroid myopathy at 4.5%, whereas patients receiving 8 mg or less experienced none of these three side effects.
Tapering Schedule
Dexamethasone should be used for the shortest possible time at the lowest possible dose and then reduced gradually . A commonly used slow taper is:
| Period | Dose |
|---|---|
| Week 1 | 4 mg, 2 times daily |
| Week 2 | 4 mg, 1 dose daily |
| Week 3 | 2 mg, 1 dose daily |
| Week 4 | 1 mg, 1 dose daily, then stop |
In patients without symptoms after surgery, the medication may be stopped rapidly within 3 days . Your treatment team determines which schedule to use.
If You Are Receiving Immunotherapy, This Section Matters Immune checkpoint inhibitors, such as nivolumab, pembrolizumab, and atezolizumab, work by stimulating the immune system, whereas dexamethasone suppressesit. Giving both medications at high doses simultaneously is problematic.
In a study published in 2018 involving 640 patients with lung cancer, those taking at least a daily 10 mg prednisone-equivalent steroid dose, approximately 1.5 mg dexamethasone, when starting immunotherapy had response rates fall from 19% to 6%, and median overall survival decreased from 12.1 months to 5.4 months .
However, a second study published in 2019 substantially changed the picture: the reason for steroid use was decisive. Survival was 2.2 months among those receiving steroids to relieve cancer symptoms, whereas those taking them for a non-cancer reason , such as asthma, COPD, or autoimmune disease, had survival of 10.7 months, almost the same as those not taking steroids. In multivariable analysis, the survival effect of steroid use for non-cancer reasons was not significant.
The Correct Interpretation: Steroid use is often a markerof disease severity rather than its sole cause. There are two practical implications: (1) before starting immunotherapy, reduce the steroid dose when possible below 10 mg prednisone equivalent ; (2) however, do not withhold steroids from a symptomatic patient who genuinely needs them. Leaving a patient with cerebral edema untreated for the sake of immunotherapy is inappropriate; the aim is the lowest effective dose.
In a study published in 2018 involving 640 patients with lung cancer, those taking at least a daily 10 mg prednisone-equivalent steroid dose, approximately 1.5 mg dexamethasone, when starting immunotherapy had response rates fall from 19% to 6%, and median overall survival decreased from 12.1 months to 5.4 months .
However, a second study published in 2019 substantially changed the picture: the reason for steroid use was decisive. Survival was 2.2 months among those receiving steroids to relieve cancer symptoms, whereas those taking them for a non-cancer reason , such as asthma, COPD, or autoimmune disease, had survival of 10.7 months, almost the same as those not taking steroids. In multivariable analysis, the survival effect of steroid use for non-cancer reasons was not significant.
The Correct Interpretation: Steroid use is often a markerof disease severity rather than its sole cause. There are two practical implications: (1) before starting immunotherapy, reduce the steroid dose when possible below 10 mg prednisone equivalent ; (2) however, do not withhold steroids from a symptomatic patient who genuinely needs them. Leaving a patient with cerebral edema untreated for the sake of immunotherapy is inappropriate; the aim is the lowest effective dose.
An Additional Concern in Brain Tumors: A 2024 meta-analysis combining twenty-two studies reported that high-dose dexamethasone was associated with shorter survival in glioblastoma, with risk approximately 1.5-1.6 times higher. However, this does not prove causation: patients receiving more steroids are already in poorer condition. The evidence was rated low quality. The message remains the same: avoid unnecessarily high doses and prolonged use.
4. Direct Cancer Treatment: Multiple Myeloma, Lymphoma, and Leukemia
This section, absent from our previous article, is essential to understanding dexamethasone. In cancer cells of lymphoid origin, dexamethasone acts through the glucocorticoid receptor and directly triggers cell death. Here, the medication is not supportive treatment but chemotherapy itself.
| Condition | Role of Dexamethasone | Typical Dose |
|---|---|---|
| Multiple myeloma | A backbone of almost all combinations, including VRd, DRd, KRd, and DVd | 40 mg once weekly (days 1, 8, 15, and 22). In patients over 75 or those who are frail: 20 mg |
| Acute lymphoblastic leukemia | Part of regimens such as Hyper-CVAD; preferred over prednisone because of good cerebrospinal fluid penetration | 40 mg/day on days 1-4 and 11-14 (reduced in patients over 60) |
| Lymphomas | Used in salvage regimens such as R-DHAP and as steroid pretreatment in bulky disease | Varies by regimen |
One of Oncology's Most Instructive Lessons: Higher Doses Do Not Mean Better Results
The ECOG E4A03 study in 445 newly diagnosed patients with myeloma compared lenalidomide combined with high-dose dexamethasone, 480 mg monthly, against low-dose weekly dexamethasone, 160 mg monthly.
The high-dose arm produced a higher response rate but more patients died. The independent monitoring board stopped the study early, and patients receiving high doses were switched to the low-dose arm. Today's standard in myeloma is 40 mg once weekly, with a trend toward further dose reductions.
The ECOG E4A03 study in 445 newly diagnosed patients with myeloma compared lenalidomide combined with high-dose dexamethasone, 480 mg monthly, against low-dose weekly dexamethasone, 160 mg monthly.
| High dose | Low dose | |
|---|---|---|
| Response rate | 79% | 68% |
| 1-year survival | 87% | 96% |
| Deep vein thrombosis (within 4 months) | 26% | 12% |
| Infection / pneumonia | 16% | 9% |
| Serious adverse effects (grade ≥3) | 52% | 35% |
| Early death (<4 months) | 5% | Below 1% |
Uses Outside Oncology
- Autoimmune and inflammatory conditions: rheumatoid arthritis, lupus, vasculitis, and inflammatory bowel diseases
- Allergic conditions: severe allergic reactions, angioedema, and drug-related rashes
- Respiratory conditions: asthma attacks, COPD exacerbations, and croup, using a single dose in children
- Adrenal insufficiency: replacement therapy at very low doses, 0.25-0.5 mg/day
- Fetal lung maturation during pregnancy: to help mature the baby's lungs when preterm birth is threatened
- Altitude sickness, certain eye conditions, and after organ transplantation
COVID-19: A Molecule's Broadest Application
In 2020, the RECOVERY trial showed that dexamethasone saved lives in severe COVID-19. The dose was straightforward: 6 mg daily for up to 10 days.
RECOVERY — 28-day mortality
Dexamethasone (n=2104) vs standard care (n=4321)
The risk ratio in ventilated patients was 0.64; in those receiving oxygen, 0.82. Patients who did not require respiratory support showed no benefit and had numerically worse outcomes, with a risk ratio of 1.19.
The most important part of this table is the bottom three rows. Dexamethasone saves lives in the severe phase of illness, when an excessive immune response damages the lungs. In contrast, it provides no benefit in mild disease and may cause harmbecause the body needs to fight the virus at that stage. Current World Health Organization guidance follows the same approach: low-dose corticosteroids are given for 7-10 days in severe or critical COVID-19, but not in non-severe cases. This illustrates the broadest lesson about corticosteroids: a powerful medication for the right patient can be an unnecessary risk for the wrong patient.
Side Effects
Dexamethasone side effects fall into two groups: those occurring with short-term use , such as a few days of chemotherapy premedication, and problems accumulating with long-term use over weeks or months.
With Short-term Use
| Side Effect | What Can Help |
|---|---|
| Insomnia, restlessness, or a burst of energy | Taking the dose in the morning is the most effective solution. If two doses are needed, the second should be taken early in the afternoon; an evening dose significantly disrupts sleep. |
| High blood sugar | See the section below |
| Increased appetite | Temporary; returns to normal after the medication is stopped |
| Facial flushing and hot flashes | Generally resolve on their own |
| Heartburn and indigestion | Take tablets with food rather than on an empty stomach |
| Mood swings | Sometimes called steroid days; a feeling of crashing may occur on days when the medication is stopped |
Blood Sugar: The Most Frequently Overlooked Side Effect
Corticosteroids raise blood sugar. A meta-analysis reported high blood sugar in 32%of steroid-treated patients and steroid-induced diabetes in 19% of them.
An Important Pitfall: With steroid-induced hyperglycemia, fasting blood sugar may be normal. With short-acting steroids, elevations are particularly noticeable in the afternoon and evening, whereas long-acting dexamethasone can keep blood sugar elevated throughout the day. Checking only morning fasting glucose can therefore be misleading, and HbA1c can also conceal the problem early on. Appropriate monitoring: fingerstick measurements before meals and 2 hours after meals. Patients with diabetes may temporarily need higher insulin doses. With a long-acting steroid such as dexamethasone, a basal-bolus insulin regimen is preferred.
With Long-term Use
| Problem | Details |
|---|---|
| Steroid myopathy | With prolonged use, it occurs in 50-60% of patients and is the most common cause of medication-induced muscle disease. The hip and thigh muscles are affected first and most severely; difficulty rising from a chair or climbing stairs is typical. Fluorinated steroids such as dexamethasone carry a greater risk. The muscle enzyme CK is generally normal. Improvement begins 3-4 weeks after dose reduction, but full recovery may take months. |
| Cushingoid appearance | A rounded moon face, fat accumulation around the neck and shoulders, abdominal fullness, thin skin, and bruising. After the medication is stopped, these changes gradually reverse. |
| Osteoporosis | Bone loss is fastest during the first 3-6 months. With prolonged use, calcium and vitamin D, and bone-protective medications if necessary, are considered. |
| Avascular necrosis | Usually affects the hip joint; new hip or groin pain that worsens with walking should be investigated. |
| Susceptibility to infection | Fever, coughing, and urinary symptoms should not be dismissed. Because steroids can suppress fever, signs of infection may be subtle. |
| Psychiatric effects | These range from restlessness to serious conditions such as agitation, confusion, and psychosis. Severe symptoms occur particularly with doses above 12 mg daily and generally begin within the first 5 days . After dose reduction, approximately 92% of patients recover completely. |
| Eyes | Cataracts and raised eye pressure; eye examinations are recommended with prolonged use |
| High blood pressure and edema | Less expected with dexamethasone than with other steroids because it does not retain salt, but still possible |
Is Gastric Protection Really Necessary? Many sources, including our previous article, recommend gastric protection for everyone taking steroids. The data do not fully support this. A large case-control study found the following risks of bleeding peptic ulcers:
- Corticosteroids alone: 1.63-fold — whether this increase is causal or related to the underlying disease is unclear
- Painkillers (NSAIDs) alone: 3.20-fold
- Corticosteroids + NSAIDs together: 4.80-fold
When Is Pneumocystis Pneumonia (PCP) Prophylaxis Needed? Long-term steroids increase the risk of serious pneumonia caused by the opportunistic fungus Pneumocystis jirovecii . The traditional threshold is a daily dose of 20 mg prednisone equivalent (approximately 3 mg dexamethasone) continued for longer than one month . The preventive medication is trimethoprim-sulfamethoxazole.
However, current data support a more measured approach in patients with brain tumors. In a cohort of 3225 patients receiving radiotherapy with concurrent temozolomide, the PCP incidence was only 0.56% . The number of patients needing routine prophylaxis to prevent one case was 288 , whereas the corresponding number for serious medication-related blood count suppression was 39. Routine prevention may therefore cause more harm than it prevents. Today's recommendation is to reserve prophylaxis for patients at genuinely high risk , such as those receiving prolonged high-dose steroids or with marked lymphopenia.
However, current data support a more measured approach in patients with brain tumors. In a cohort of 3225 patients receiving radiotherapy with concurrent temozolomide, the PCP incidence was only 0.56% . The number of patients needing routine prophylaxis to prevent one case was 288 , whereas the corresponding number for serious medication-related blood count suppression was 39. Routine prevention may therefore cause more harm than it prevents. Today's recommendation is to reserve prophylaxis for patients at genuinely high risk , such as those receiving prolonged high-dose steroids or with marked lymphopenia.
How to Take It: Practical Rules
- Take it in the morning. If taking a single dose, take it after breakfast. This mimics the body's cortisol rhythm and reduces insomnia.
- Take it with food and swallow it with a glass of water. Do not chew the tablets.
- If two doses are needed, take the second early in the afternoon if possible.
- Do not take it together with antacids — they may reduce absorption. Take the antacid 1 hour before or 2 hours after dexamethasone. Proton pump inhibitors have no such restriction.
- If a dose is missed: If less than 12 hours have passed, take it as soon as you remember; if more than 12 hours have passed, skip it and continue the usual schedule. Do not take a double dose.
- Store at room temperature, away from light and moisture.
- Renew your prescription before it runs out. An abrupt interruption is dangerous for people taking it long term.
Never stop dexamethasone abruptly on your own.
When the body receives an external steroid, it slows its own cortisol production. This suppression develops when high doses continue for longer than 3-4 weeks . If the medication is stopped suddenly, the body cannot produce the cortisol it needs, and adrenal insufficiency may develop, causing extreme weakness, nausea and vomiting, abdominal pain, low blood pressure, and fever. Severe cases can be life-threatening.
When the body receives an external steroid, it slows its own cortisol production. This suppression develops when high doses continue for longer than 3-4 weeks . If the medication is stopped suddenly, the body cannot produce the cortisol it needs, and adrenal insufficiency may develop, causing extreme weakness, nausea and vomiting, abdominal pain, low blood pressure, and fever. Severe cases can be life-threatening.
- For courses shorter than 3-4 weeks , such as chemotherapy premedication, tapering is unnecessary and the medication can be stopped directly.
- With long-term use, higher doses are initially reduced quickly; after reaching the physiological range, approximately 0.25-0.5 mg/day dexamethasone, further reductions proceed slowly as tapering continues.
- Full adrenal recovery may take monthsand sometimes years . During this period, additional doses may be needed with feverish illness, surgery, or serious stress. Discuss this with your doctor in advance.
Drug Interactions
Dexamethasone is broken down by the liver enzyme CYP3A4 and also increases this enzyme's activity to some extent. This dual role explains its interactions.
| Group | Examples | Effect | Action |
|---|---|---|---|
| Agents that increase dexamethasone levels | Itraconazole, ketoconazole, voriconazole, clarithromycin, ritonavir, aprepitant, and grapefruit | Blood levels increase with itraconazole by 3.7-foldand with aprepitant by approximately 2-fold in total. | Reduce the dose, by 50% with aprepitant |
| Agents that reduce dexamethasone levels | Phenytoin, carbamazepine, phenobarbital, rifampicin, and St. John's wort | Reduced effect; edema control may deteriorate, with adrenal crisis risk when the medication is stopped | In patients with brain tumors, when possible, levetiracetam or other antiseizure medications that do not affect these enzymes are preferred |
| Blood thinners | Warfarin | The interaction is unpredictable: INR may either rise or fall | When starting and stopping dexamethasone, monitor INR frequently |
| Painkillers | Ibuprofen, naproxen, aspirin | The risk of gastric bleeding increases through a combined, multiplying effect | For pain, paracetamol is tried first |
| Live vaccines | Measles-mumps-rubella, chickenpox, shingles (live formulation), yellow fever, and nasal influenza vaccine | During immunosuppression, they are not given | The threshold is a daily dose of 3 mg dexamethasone equivalent or more for longer than 14 days. After stopping the medication, wait at least 1 month before vaccination. Killed/inactivated vaccines, including influenza, COVID, and pneumococcal vaccines, can be given — the response may be reduced, but there is no contraindication. |
| Alcohol | Increases stomach problems and blood sugar fluctuations | Should be limited |
Dexamethasone itself can also affect the levels of other medicationsbecause it increases CYP3A4 activity to some extent. At nausea-prevention doses, such as 8-12 mg for a few days, this effect is generally not clinically significant; however, it may matter at cerebral edema doses of 16-24 mg/day and during prolonged use. Caution is needed with medications that have narrow safety margins, including tacrolimus, ciclosporin, and certain targeted therapies.
Pregnancy, Breastfeeding, and Fertility
We Are Correcting This Section Our previous article stated that "dexamethasone may affect sperm production and harm the baby during pregnancy; use contraception." This statement is incorrect and creates unnecessary anxiety. That warning applies to cytotoxic chemotherapy medications, not corticosteroids.
The actual picture is more nuanced:
- Dexamethasone crosses the placenta readily — unlike prednisolone. Prednisolone is largely inactivated in the placenta, whereas dexamethasone reaches the baby in its active form.
- This property makes it necessary in some situations rather than harmful. This is precisely why dexamethasone or betamethasone is used to promote fetal lung maturation when preterm birth is threatened. The product information also states that short-term antenatal use to prevent respiratory distress syndrome does not pose a risk to mother or baby.
- Known risks relate to prolonged use: reduced placental and birth weight, and temporary adrenal suppression in the newborn. Animal studies show a cleft palate signal, but its relevance to humans is uncertain.
- The Turkish summary of product characteristics states: "It should not be used during pregnancy unless necessary."
- Breastfeeding: Small amounts pass into breast milk. Single doses and short courses generally do not prevent breastfeeding. High doses and continuous use require medical assessment because of possible adrenal suppression in the infant.
- Fertility: There is no evidence that dexamethasone causes permanent infertility. Prolonged high-dose use may temporarily suppress the hormonal axis; this effect reverses when the medication is stopped.
The appropriate approach: Rather than automatic avoidance and a requirement for contraception, use a reasoned benefit-risk assessment. Tell your doctor if you are pregnant or planning a pregnancy.
Frequently Asked Questions
- Is Dexamethasone a Cancer Treatment or a Supportive Medication?
- Both. In solid tumors, such as breast, lung, and bowel cancers, it provides supportive care by preventing nausea, allergy, and edema. In contrast, in multiple myeloma, lymphoma, and leukemia, it directly kills cancer cells and is an essential part of the regimen.
- Why Is It Sometimes Called Cortisone?
- All corticosteroids are commonly referred to as cortisone. Dexamethasone is a much more potent derivative of cortisol. Although they belong to the same family, their potency and duration differ greatly: 0.75 mg dexamethasone is equivalent to 20 mg hydrocortisone.
- Does It Cause Weight Gain? Can I Lose the Weight?
- Short courses increase appetite but generally do not cause lasting weight gain. Long-term use can cause both weight gain and redistribution of fat to the face, neck, and abdomen. Both gradually reverse after the medication is stopped, although this may take months.
- I Feel Very Energetic for Two Days After Chemotherapy, Then Very Tired. Is This Normal?
- Yes, this is very typical. Energy and insomnia increase on days when premedication steroids are taken, followed by a crashing feeling when they are stopped. This fluctuation is part of the medication's usual course and resolves within a few days. If severe, the dose and timing can be reviewed.
- Can I Be Vaccinated While My Immunity Is Suppressed?
- Killed/inactivated vaccines such as influenza, COVID, and pneumococcal vaccines can and should be given. The response may be somewhat weaker, but there is no contraindication. Live vaccines such as chickenpox, MMR, yellow fever, and live shingles vaccines, when patients are taking at least 3 mg dexamethasone equivalent daily for longer than 14 days, are not given; vaccination is assessed at least one month after stopping.
- I Take Dexamethasone and Am Having Surgery. What Should I Do?
- Always tell your anesthesia and surgical teams. In patients taking long-term steroids, the adrenal glands may not respond adequately to surgical stress, so an additional steroid dose may be needed. Do not stop the medication on your own.
- My Blood Sugar Has Risen. Should I Stop the Medication?
- No, do not stop it on your own. Steroid-induced high blood sugar is an expected and manageable condition. The solution is more frequent glucose monitoring and temporary adjustment of diabetes treatment if necessary, rather than stopping the medication.
- I Am Receiving Immunotherapy. Will Dexamethasone Interfere with Treatment?
- High doses, above 1.5 mg dexamethasone equivalent daily, may reduce effectiveness when immunotherapy begins. However, much of this association reflects the fact that patients needing steroids are already more severely ill. If you genuinely need steroids, they should not be avoided; the aim is the lowest effective dose for the shortest possible time. Your oncologist makes that decision.
- How Long Can I Take It?
- Duration depends on the purpose: 1-3 days for chemotherapy premedication, 1-4 days for nausea prevention, one day a week for months in myeloma, and the shortest possible duration for cerebral edema. The general rule is: the lowest effective dose for the shortest possible time.
Transparency Note Points we could not verify in this article: (1) Prices were taken from Turkish drug databases' August-September 2026 updates; the official TİTCK list date could not be confirmed directly. (2) The list of dexamethasone products in Turkey was compiled from a database without a product-by-product comparison against the TİTCK licensed-product list. (3) The 2023 MASCC/ESMO guideline's complete dose tables could not be viewed in the primary source; the milligram values in this article were taken from the ASCO guideline and aprepitant product information. (4) For avascular necrosis, cataracts, glaucoma, and osteoporosis, no numerical frequencies were givenbecause reliable rates could not be verified, so only qualitative information was provided. (5) Exact dose-specific percentages for steroid-induced psychiatric effects could not be verified. (6) No numerical oral bioavailability value was provided for dexamethasone. (7) The morning-dosing recommendation is based on expert opinion ; randomized evidence could not be found. Medication prices change frequently in Turkey; confirm them through the pharmacy's system before purchasing.
This article is for information only and does not replace personal medical advice. Dexamethasone is powerful, and its dose, duration, and discontinuation must be determined by a physician. The dose schedules on this page are provided to help you understand your treatment, not adjust it yourself.
References
- DEKORT 4 mg tablet Kısa Ürün Bilgisi, Deva Holding A.Ş.; revision 05.06.2023.
- Turkish drug price databases, August-September 2026 updates.
- Docetaxel Injection US Prescribing Information (NDA 203551), 2024; Paclitaxel Injection US Prescribing Information; ABRAXANE (nab-paclitaxel) US Prescribing Information; Pemetrexed Injection US Prescribing Information (NDA 208419).
- EMEND (aprepitant) US Prescribing Information — dexamethasone dose-reduction section.
- Hesketh PJ, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 2020.
- 2023 MASCC/ESMO Antiemetic Guideline Update. Support Care Cancer 2023.
- Navari RM, et al. Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 2016;375:134-42.
- Vecht CJ, et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors. Neurology 1994;44:675-80.
- Ryken TC, et al. The role of steroids in the management of brain metastases: evidence-based guideline. Congress of Neurological Surgeons.
- Dietrich J, et al. Corticosteroids in brain cancer patients: benefits and pitfalls. Neuro-Oncology 2016;18(9):1191-4.
- Arbour KC, et al. Impact of baseline steroids on efficacy of PD-1 and PD-L1 blockade in patients with NSCLC. J Clin Oncol 2018;36:2872-8.
- Ricciuti B, et al. Immune checkpoint inhibitor outcomes for patients with NSCLC receiving baseline corticosteroids for palliative versus nonpalliative indications. J Clin Oncol 2019;37:1927-34.
- Rajkumar SV, et al. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma (ECOG E4A03). Lancet Oncol 2010;11:29-37.
- RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 2021;384:693-704.
- World Health Organization, Therapeutics and COVID-19: living guideline, August 2025.
- Beuschlein F, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. Eur J Endocrinol 2024;190:G25-G51.
- Peptic ulcer bleeding and combined corticosteroid-NSAID use, case-control study. Drug Safety 2018.
- Pneumocystis prophylaxis and temozolomide chemoradiotherapy, Ontario cohort. Neuro-Oncology 2022;24(10):1738.
- Corticosteroid myopathy, StatPearls; ASHP glucocorticoid equivalence table.
- Dexamethasone dose and glioblastoma survival: systematic review and meta-analysis. Cancers 2024;16:1393.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.